Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

WESCO Expands Presence In Electronics With Anixter Buyout

Published 01/13/2020, 09:01 PM
Updated 07/09/2023, 06:31 AM

WESCO International, Inc. (NYSE:WCC) is finally acquiring Anixter International (NYSE:AXE) in a transaction valued at approximately $4.5 billion. Per the deal, Anixter shareholders will receive $100 per share in cash, stock and preferred stock.

The transaction is subject to certain approvals and other customary closing conditions.

Notably, Anixter's prior agreement to be acquired by Clayton, Dubilier & Rice, LLC had been terminated.

Anixter — a supplier of network and security, electrical and electronic plus utility power solutions — is best known for communication and security products. The consolidated company will likely be a premier electrical and data communications distribution player in North America.

WESCO International, Inc. Price and Consensus

Deal Rationale

The deal has immense growth opportunities for WESCO. Strategically, this deal is a perfect fit as it will make the combined entity a leading electrical distributor in North America. The buyout will expand the acquirer’s product portfolio in industrial, construction and utility areas.

This apart, the acquisition will provide WESCO with additional expertise in industrial, construction, utility and new cross-selling opportunities.

The deal will also be accretive to WESCO’s financials. Revenues of the combined company are expected to be $17 billion in 2019. In addition, the company is expected to generate approximately 12% of revenues from outside North America. This will significantly add to its top-line numbers. The revenue growth will be driven by cross-selling opportunities.

In addition, the deal will be immediately accretive to WESCO’s earnings in the first full year of ownership. Further, it is expected to expand the company’s margin and EPS growth, and generate strong free cash in the future.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Notably, WESCO expects net debt-to-EBITDA ratio to be 4.5 at the close of the deal. The company plans to use the cash flows and synergies of the combined company to reduce its leverage.

The deal will likely to aid synergies for WESCO in the electronics industry, which is riding on growing proliferation of electric components and electrical equipment in every major sector across the world. WESCO expects to realize annualized run-rate cost synergies of more than $200 million by the end of third year.

Hence, Anixter’s comprehensive product portfolio is expected to contribute significantly to WESCO’s top-line growth in the long run.

These positives might help WESCO to gain investor confidence.

Bottom Line

Acquisitions that are a strategic fit for the company have been playing an instrumental role in shaping up WESCO’s growth trajectory over the past few years.

Notably, the company’s M&A activity helped it in fortifying the product and services portfolio. Further, these tactical actions bolstered its customer reach.

In third-quarter 2019, benefits from acquisitions drove the company’s results. The latest deal is likely to expand key offerings to further add capabilities to its portfolio strength.

Zacks Rank & Stocks to Consider

Currently, WESCO carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the broader technology sector include MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI) and Fiverr International Ltd. (NYSE:FVRR) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term earnings growth for MACOM Technology and Fiverr is currently projected at 15% and 44.2%, respectively.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



WESCO International, Inc. (WCC): Free Stock Analysis Report

Anixter International Inc. (AXE): Free Stock Analysis Report

MACOM Technology Solutions Holdings, Inc. (MTSI): Free Stock Analysis Report

Fiverr International Lt. (FVRR): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.